Search

everythinglearnresearchcommunity

for

Search:↓

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Modified keratin binds better to hair, especially bleached hair.

Isotretinoin reduced inflammation in tufted hair folliculitis, but hair tufting remained.

Transfersomes are better than liposomes for targeting hair follicles in alopecia treatment.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

A new treatment using gold nanoclusters can safely reduce unwanted hair growth.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Low-intensity ultrasound may prevent hair loss during taxane chemotherapy.

FGF-2&D/P nanoparticles can help treat hair loss.

The nanoparticles show promise for cancer treatment and diagnosis with fewer side effects.

Docetaxel is effective against various cancers but mainly causes neutropenia.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Fesoterodine is effective and safe for elderly patients with overactive bladder.

TrichoFoam™ is a stable option for personalized hair loss treatment with most ingredients remaining effective for 90-180 days.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

For better medication adherence in benign prostatic hyperplasia treatment, tamsulosin and finasteride should be packaged together and taken at the same time.

Gefitinib can cause hair and eyebrow darkening.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

The research shows that hydrogen bonds greatly affect the crystal structure of a Finasteride derivative.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

New dissolving and implantable microneedle patches have been created for a long-lasting, non-invasive delivery of the drug finasteride.

New compounds were found to help increase hair growth and decrease hair loss.

The material improved facial wrinkles and skin appearance.